Wanbury
Wanbury Share Price Chart
Wanbury last traded at ₹193.00 (2026-10-13). Over the past month the stock moved -20.2%, three months the stock moved -32.8%, year the stock moved -22.8%. Its closing range over 52 weeks is ₹177.20 – ₹287.25, with the latest close 32.8% below the high.
Closing prices up to 2026-10-13.
About Wanbury
Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research[1]
Business Overview:[1] WL is a pharmaceutical company with a presence in the API global market and domestic branded Formulation. It’s majorly into Active Pharmaceutical Ingredient (API) Sales & Marketing in over 50 countries and Pan-India Formulation presence.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Wanbury reported sales of ₹165.58 crore (+1.5%) and net profit of ₹3.24 crore (-76.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 165.58 | 16.23 | 9.80 | 3.24 | 0.93 |
| Mar 2026 | 164.58 | 29.84 | 18.13 | 21.70 | 6.21 |
| Dec 2025 | 162.45 | 26.68 | 16.42 | 15.76 | 4.52 |
| Sep 2025 | 160.06 | 25.78 | 16.11 | 15.18 | 4.35 |
| Jun 2025 | 163.18 | 24.44 | 14.98 | 13.49 | 4.10 |
| Mar 2025 | 172.00 | 29.63 | 17.23 | 20.26 | 6.18 |
| Dec 2024 | 133.45 | 13.95 | 10.45 | 1.22 | 0.37 |
| Sep 2024 | 161.19 | 20.01 | 12.41 | 8.02 | 2.45 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +11.6% | -8.3% | +23.4% | +24.5% | -0.7% | +21.7% | -4.3% | +1.5% |
| Operating profit growth | +15.4% | -34.0% | +63.2% | +122.6% | +28.8% | +91.3% | +0.7% | -33.6% |
| Net profit growth | +9.0% | -88.1% | +150.7% | +1197.1% | +89.3% | +1191.8% | +7.1% | -76.0% |
| EPS growth | +8.9% | -88.2% | +150.2% | +1181.2% | +77.6% | +1121.6% | +0.5% | -77.3% |
| OPM % | 12.4% | 10.5% | 17.2% | 15.0% | 16.1% | 16.4% | 18.1% | 9.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Wanbury reported sales of ₹650.00 crore (+8.3%) and net profit of ₹66.00 crore (+112.9%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 650.00 | 107.00 | 16.00 | 66.00 | 18.93 |
| Mar 2025 | 600.00 | 76.00 | 13.00 | 31.00 | 9.32 |
| Mar 2024 | 557.00 | 73.00 | 13.00 | 56.00 | 17.09 |
| Mar 2023 | 485.00 | 26.00 | 5.00 | -10.00 | -3.18 |
| Mar 2022 | 511.00 | 36.00 | 7.00 | 81.00 | 24.94 |
| Mar 2021 | 392.00 | 18.00 | 5.00 | -13.00 | -5.04 |
| Mar 2020 | 367.00 | 23.00 | 6.00 | 64.00 | 25.79 |
| Mar 2019 | 391.00 | 16.00 | 4.00 | -25.00 | -10.48 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +5.7% | -6.1% | +6.8% | +30.4% | -5.1% | +14.8% | +7.7% | +8.3% |
| Operating profit growth | – | +43.8% | -21.7% | +100.0% | -27.8% | +180.8% | +4.1% | +40.8% |
| Net profit growth | – | – | -120.3% | – | -112.3% | – | -44.6% | +112.9% |
| EPS growth | – | – | -119.5% | – | -112.8% | – | -45.5% | +103.1% |
| OPM % | 4.0% | 6.0% | 5.0% | 7.0% | 5.0% | 13.0% | 13.0% | 16.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Wanbury.
Get Free AI Stock Analysis FREE →Latest News
-
Wanbury's arm launches ‘berrysoft’ baby product range across multiple states in India
-
Wanbury's arm launches ‘berrysoft’ baby product range across multiple states in India
-
Wanbury's arm launches ‘berrysoft’ baby product range across multiple states in India
-
Wanbury standalone net profit declines 75.98% in the June 2026 quarter - Business Standard
-
Wanbury releases 40.65% promoter pledge, cuts borrowing costs to sub 10% - scanx.trade
-
Wanbury rises as its Patalganga facility completes MFDS inspection successfully
-
Wanbury jumps on strengthening Coriminic brand with launch of Coriminic CPM Drops
-
Wanbury strengthens Coriminic brand with launch of Coriminic CPM Drops
Frequently Asked Questions
What is Wanbury's current stock price?
Wanbury shares were last quoted at ₹193.00 (-1.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Wanbury?
Wanbury has a price-to-earnings (P/E) ratio of 18.23 and a price-to-book (P/B) ratio of 19.13. The industry P/E is 53.33.
What is the 52-week high and low of Wanbury?
The 52-week high of Wanbury is ₹360.00 and the 52-week low is ₹162.00.
What is the market cap of Wanbury?
The market capitalisation of Wanbury is about ₹783.26 crore.
How did Wanbury perform in its latest quarterly results?
In the latest quarter (Jun 2026), Wanbury reported sales of ₹165.58 crore (+1.5%) and net profit of ₹3.24 crore (-76.0%), compared with the same quarter last year.
Is Wanbury a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Wanbury has a 3-year ROE of 83.00%, 3-year profit growth of 107.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Wanbury?
Promoters hold about 43.01% of Wanbury.
Which sector does Wanbury belong to?
Wanbury belongs to the Pharmaceuticals & Drugs sector.